LGALS3 and acute myeloid leukemia: Kargar-sichani found that gene expression of Gal-3 and IL-6 was significantly upregulated in AML-EV-treated normal BM-MSCs, while the highest concentration of AML-EVs had no significant effect on both gene expressions [121].